Faizan Farooque

Faizan Farooque

InvestorPlace Contributor

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Wait For the Pullback Before Buying Autodesk Stock

By Faizan Farooque, InvestorPlace Contributor

ADSK stock has gained precipitously over the last month as investors price in a recovery that has yet to take place fully.

Energy Transfer Has the Legs to Beat the Sell-Off

By Faizan Farooque, InvestorPlace Contributor

ET stock trades at a discount at the moment, and savvy investors should consider picking it up since it offers excellent upside potential.

Co-Diagnostics Stock Is a Fun Day Trade but It Is No Investment

By Faizan Farooque, InvestorPlace Contributor

CODX stock will start to tumble back to earth as more competitors enter the testing space, and the impact of Covid-19 subsides.

Coronavirus Hype Is Boosting iBio Shares to Unrealistic Levels

By Faizan Farooque, InvestorPlace Contributor

The enthusiasm surrounding iBio stock is warranted since the company is yet to deliver a viable, commercially successful vaccine.

Want to Buy the Best REITs? Here Are 5 New Picks from LaSalle

By Faizan Farooque, InvestorPlace Contributor

LaSalle is an expert in real estate investing, and we are checking out its latest quarterly picks as we hunt for the best REIT stocks.

Load More